Combination of masofaniten plus enzalutamide continues to be well tolerated with durable reductions in PSA in patients with ...

Shionogi Continues Global Commitment to Advances in Infectious Disease with Key Data Presentations from Its Expanding Product Portfolio at IDWeek 2024 ...

A coordinated effort called “National Only Citizens Vote” has been rolled out this week by a coalition of people pushing ...

The recent ESMO 2024 data highlighted significant advancements in immunotherapy. Check out the results from Merck, BMY, ...

Tempus Announces Four Abstracts Accepted For Presentation at the European Society for Medical Oncology Congress 2024 ...

TME Pharma N.V. (Euronext Growth Paris: ALTME), a clinical stage biotechnology company focused on developing novel therapies for treatment of cancer by targeting the tumor microenvironment (TME), ...

We've found a selection of fonts great for presentations. Most of these are standard system fonts in PowerPoint and many are ...

Nuvation Bio Inc. (NYSE: NUVB), a late clinical-stage, global biopharmaceutical company tackling some of the greatest unmet needs in oncology, today a ...

Event at Bustleton Library Bustleton Library, 10199 Bustleton Ave., will host a visit by the city Department of Public Health ...

A copy of the presentation materials can be accessed on the “Publication” section of the Company’s website at www.bioatla.com once the presentation has concluded. About BioAtla®, Inc.

Larimar will present three posters during the conference, one of which will also be presented as an oral presentation. The poster presentations are as follows: Effect of nomlabofusp administration on ...

SOPHiA GENETICS (Nasdaq: SOPH), a cloud-native healthcare technology company and a global leader in data-driven medicine, will be presenting multiple posters at the European Society for Medical ...